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Summary
Objective: This study aims to apply gene expression profiling technology to gain insight into the molecular regulation of mesenchymal
chondrogenesis.
Methods: The experimental system consists of micromass cultures of C3H10T1/2 cells, a murine multipotential embryonic cell line, treated
with the chondroinductive growth factor, bone morphogenetic factor-2 (BMP-2). In this system, chondrogenic differentiation characterized by
both morphological changes and cartilage matrix gene expression has been shown to be completely dependent upon BMP-2 treatment and
the high cell plating density of micromass cultures. To identify candidate genes that may have key functional roles in chondrogenesis, we
have applied subtractive hybridization to isolate genes whose expression is significantly up- or down-regulated during chondrogenesis. RNA
was isolated from micromass cultures treated with BMP-2 for 24 h and analysed for representational differences by means of a subtractive
hybridization screening method.
Results: Sixteen different genes were identified whose expression was up-regulated between two- and 12-fold by B,P-2, and twelve different
genes were identified whose expression was down-regulated between two- and seven-fold by BMP-2.
Conclusions: The potential of this screening methodology to identify new BMP-2 regulated genes is suggested by the fact that a majority of
the identified genes are indeed novel. Identification and characterization of these genes should provide insight as to how chondrogenesis is
regulated and also should provide important new markers for the study of osteoarthritis. © 2002 OsteoArthritis Research Society
International
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Chondrogenesis, the differentiation of mesenchymal
cells into chondrocytes, is crucial to the development and
maturation of the skeleton, since the cartilage anlage is the
model for bone formation. Cartilage development thus
includes the differentiation of mesenchymal stem cells into
chondrocytes, followed by the maturation and eventual
hypertrophy and death of these chondrocytes. That
chondrogenesis can be induced at ectopic extra-skeletal
sites by the implantation of demineralized bone matrix led
to the isolation of chondroinductive factors1,2. A detailed
analysis of the protein extracts from demineralized bone
led to the identification of members of the transforming
growth factor- (TGF-) superfamily as constituents that
are able to ectopically induce chondrogenesis and bone3–8.
The key osteo- and chondroinductive components include
the bone morphogenetic proteins or BMPs.
The bone morphogenetic proteins play crucial roles in
both cartilage and bone development. For example,
expression studies have shown that several BMP family
members are expressed at sites of embryonic cartilage and23bone formation, and bone repair9–15. BMPs have also been
shown to selectively promote chondrogenesis and osteo-
genesis and inhibit myogenesis in a variety of in vitro
culture systems16–29. In particular, the multipotential
C3H10T1/2 embryonic murine mesenchymal cell line,
which has been demonstrated to differentiate into muscle,
fat bone and cartilage lineages upon treatment with specific
agents and culture under the appropriate conditions, has
been used as a model system of chondrogenic differen-
tiation16,18,20,28. Specifically, when C3H10T1/2 cells are
plated in high-density micromass culture, which approxi-
mates the in vivo high cell density conditions during pre-
cartilage mesenchymal condensation in the developing
limb bud, and treated with either demineralized bone
extract or purified BMP-2, the induction of chondrogenic
induction is enhanced while other differentiation linages,
such as myogenesis, is suppressed18,30.
Differential gene expression profiling has been used
widely to identify and characterize candidate genes that
play potentially important roles in a particular biological
process31,32. For example, differential hybridization
identified the basic-helix-loop-helix gene, MyoD, as a key
regulatory gene of myogenesis33.
The key elements in successful identification of
biologically relevant genes are (1) a limited and defined
number of variables between the two sets of expressed
genes, and (2) an efficient means, such a subtraction, to
reduce false positives or to confirm true positives. Among
the currently available technologies are differential display,
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CELL CULTURE
C3H10T1/2 cells were obtained from the American Type
Culture Collection and monolayer cultures were maintained
in standard polystyrene tissue culture plates (Corning
Incorporated, Corning, NY, U.S.A.) in Dulbecco’s Modified
Eagles Medium (DMEM) (BioWhittaker, Walkersville, MD,
U.S.A.) supplemented with 10% bovine calf serum (Atlanta
Biologicals, Atlanta, GA, U.S.A.), 50 U/ml penicillin and
50 mg/ml streptomycin. Cultures were incubated at
37°C and 5% CO2 and the medium was changed every
3–4 days.
The micromass culture technique was performed as
described18. Trypsinized cells were resuspended to a con-
centration of 2×107 in Ham’s F12 medium (BioWhittaker)
supplemented with 10% bovine calf serum (Atlanta
Biologicals, Atlanta, GA, U.S.A.), and plated in standard
24-well polystyrene plates (Corning Incorporated, Corning)
in drops. The cells were allowed to adhere for 3 h at 37°C
and 5% CO2, and then 1 ml of medium was added con-
taining recombinant human BMP-2 (kindly supplied by
Genetics Institute, Cambridge, MA, U.S.A.) at 75 ng/ml.
Controls were cultured in the exact same manner, without
supplementation of BMP-2. Cultures were maintained at
37°C and 5% CO2 until harvest. For longer term cultures,
the medium was changed every 3 days and fresh BMP-2
was added.ASSESSMENT OF CHONDROGENESIS: ALCIAN BLUE STAINING AND
METABOLIC SULFATE INCORPORATION
Cultures were rinsed with PBS, fixed in 4% para-
formaldehyde (Sigma) for 5 min at room temperature,
rinsed and then incubated in 1 ml of 1% Alcian blue in
0.1 N HCl (pH 1.0) overnight. After rinsing, cultures were
examined using a Wild Heerbrugg stereomicroscope and
photographed.
To estimate the production of sulfated glycosamino-
glycans, relative to total protein, cultures were labeled with
sodium [35S] sulfate (5 Ci/ml) and [3H]-leucine (1 Ci/ml)
(NEN, Boston, MA, U.S.A.) for 24 h at the indicated times.
Cultures were then rinsed extensively with PBS, fixed in 4%
paraformaldehyde and radioactivity incorporation assessed
by liquid scintillation counting.RNA ISOLATION AND SUBTRACTIVE HYBRIDIZATION
Micromass cultures were rinsed with sterile PBS,
detached from the well using a sterile micropipette tip, and
then collected into a 15 ml polypropylene conical tube and
pelleted at 2000×g and 4°C. The pellets were resuspendedin 1 ml of TriZol Reagent (Gibco) and homogenized by
repeated pipetting. After incubation at room temperature for
5 min, 200 l of chloroform was added, and mixed by
repeated inversion. After centrifugation at 12,000×g, the
aqueous phae was collected and RNA was precipitated
from the aqueous fraction with isopropanol, and spun
at 14,000×g. The RNA pellets were washed with 70%
ethanol, allowed to air dry and then resuspended in diethyl-
pyrocarbonate (DEPC) treated water. A260/280 values were
used to estimate RNA concentration and purity.
Cellular mRNA was isolated from total RNA and ampli-
fied using the Clontech SMART-PCR and was then used in
the Advantage PCR-Select subtractive hybridization kit
(Clontech) according to the manufacturer’s instructions.
The basic principle of the method is detailed in the results
section.CLONING AND CHARACTERIZATION OF CDNAS
The resulting cDNAs were then ligated into the pT-Adv
TA-cloning vector (Clontech) and TOP10F′ E. coli com-
petent cells were transformed. The transformants were
plated on LB agar plates (Gibco) containing 50 g/ml
ampicillin, 96 g/plate IPTG (Sigma) and 160 g/plate
X-Gal (Sigma). White colonies from overnight cultures were
single-picked into 5 ml of LB broth (Gibco) with 50 g/ml
ampicillin, and cultured were grown overnight and DNA
isolated using QIAprep Spin kits (Qiagen, Chatsworth, CA,
U.S.A.). cDNA inserts were sized by digesting the plasmid
and electrophoresis in 1.5% TAE/agarose.
Clones that were of sufficient size (≥200 bp) were
sequenced from purified plasmids using the M13 reverse
site that is present on the pT-Adv TA-cloning vector. An ABI
Prism Model 3700 was used to read the sequencing gel
and interpretation was performed with the accompanying
software. The resultant raw sequences were scanned
through the BLAST database for sequence homologies.
Hits were scored as positive if there was a minimum of 80%
homology to a published sequence.SLOT BLOTTING AND RT/PCR ANALYSIS OF DIFFERENTIAL GENE
EXPRESSION
Clones that contained an insert of greater than 200 bp,
0.8 g of plasmid DNA was immobilized on to nitrocellulose
(Schleicher and Schuell) using a Minifold slot blot manifold
(Schleicher and Schuell). The blot was prepared in dupli-
cate and was then ultraviolet irradiated with 120 mJ/cm2 to
cross-link the DNA. The blots were then pre-hybridized at
42°C in 10 ml of UltraHyb solution (Ambion) for 30 min.
Labeled cDNA probes were prepared from the total RNA
isolated from the BMP-2 treated and untreated micro-
mass cultures by reverse transcription using the random
hexamer method in the presence of -32P dCTP (Gibco)
and a QuickSpin column (Roche) was used to remove the
unincorporated nucleotides. Hybridization was carried out
with 1×106 counts/ml in 10 ml of UltraHyb solution 42°C.
After washing twice in 2×SSC with 0.1% SDS at 42°C and
0.1×SSC with 0.1% SDS at 52°C, blots were exposed to
film overnight at −80°C. The autoradiographs were digitally
scanned using a Kodak Image Station 440 and analysed
densitometrically using the Kodak 2d software (Kodak,
Rochester, NY, U.S.A.).
The Titan One-Tube RT-PCR Kit (Roche Molecular Bio-
chemicals, Indianapolis, IN, U.S.A.) was used for RT-PCRsubtractive hybridization, cDNA microarrays and the
recently described PCR-selected subtractive hybridization
method. PCR-selected subtractive hybridization has shown
to be a more rapid and sensitive method in the identification
of differentially expressed genes. We show that there are
detectable changes in the gene expression profile of
C3H10T1/2 cells that are grown in a chondrogenically
favorable environment. Specifically, we have identified,
cloned, and sequenced a large number of cDNAs, many of
which are novel, whose gene expression pattern was
observed to be either enhanced or suppressed by BMP-2.
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respective primers designed from published sequences:
(1) Mouse collagen type II (forward 5′-GTGAGCCAT
GAT CCGC-3; reverse, 5′-GACCAGGATTTCCAGG-
3′; type IIa: 489 bp product, type IIb: 285 bp
product)15,34.
(2) Mouse aggrecan (forward 5′-CTTTCCTGCAGAAGT
CAC-3′, reverse 5′-ACATCCTCTACTCCAGAG-3′;
1870 bp product).
(3) Mouse -Actin (forward 5′-GTGGGCCGCTCTAGGC
ACCAA-3′, reverse 5′-CTCTTTGATGTCACGCACGA
TTTC-3′; 502 bp product).
All primers were prepared by IDT Technologies
(Coralview, IA, U.S.A.). The RT-PCR products were separ-
ated by electrophoresis in 1.5% TAE/agarose gel, visual-
ized using ethidium bromide, and images were recorded
with a Kodak Image Station 440 utilizing the Kodak 2d
software (Kodak, Rochester, NY, U.S.A.).ResultsBMP-2 INDUCTION OF CHONDROGENESIS IN MICROMASS
CULTURES OF C3H10T1/2 CELLS
We have previously reported that micromass cultures of
C3H10T1/2 cells undergo chondrogenesis upon BMP-2
treatment beginning on days 2–3 of culture18. This differ-
entiation profile is reproduced here, as shown in Fig. 1(a),
where micromass cultures treated with BMP-2 and stained
with Alcian blue at 48 h of culture, clearly showed induced
chondrogenesis when compared to the control cultures.
The BMP-2 effect on chondrogenesis was also evident by
the 2.5-fold increase in normalized 35SO4 incorporation
in the BMP-2 treated cells on days 4 and 10 of culture
[Fig. 1(b)].
The BMP-2 induction of chondrogenesis was also
accompanied by the expression of chondrocyte-associated
genes as analysed by RT-PCR. As seen in Fig. 1(c), mRNA
levels of both aggrecan and collagen type II, characteristic
of chondrocytes, is elevated in the BMP-2 treated cultures.
Additionally, Fig. 1(c) shows that of the two alternatively
spliced isoforms of collagen type II mRNA, the IIb form is
significantly induced, whereas the IIa form, present in the
control cultures is up-regulated in the BMP-2 treated
cultures. As a control, -actin shows no detectable
change in expression in the presence of ectopic BMP-2.
The IIa form of collagen type II mRNA is expressed by
chondroprogenitor mesenchymal cells, whereas the IIb
form is a marker for mature chondrocytes15,34. Note that by
RT/PCR we consistently see a 75–100-fold induction of
aggrecan, a 5–8-fold induction of collagen type IIA and a
15–20-fold induction of collagent type IIB. For beta-actin we
see no change in levels. Taken together, these results
confirmed that addition of BMP-2 to these cultures
enhances the level of chondrocyte/cartilage specific gene
expression.Fig. 1. Induction of chondrogenesis in BMP-2 stimulated micro-
mass cultures of C3H10T1/2 cells. C3H10T1/2 cells were grown to
confluence, trypsinized, resuspended at a density of 1× 107/ml
and plated in micromass culture in the presence or absence of
BMP-2 (75 ng/ml). (a) Alcian blue staining. Whole mounts were
stained at 48 h of culture. (b) Sulfate incorporation. 35SO4 was
added to the culture (5 uCi/ml) for a 24 h period ending at day 7
and day 10 (3H-leucine at 1 uCi/ml was added as a control to
standardize for differences in protein levels). The ratio of 35SO4 to
3H-leucine on days 4 and 10 is shown. (c) RNA analysis. RT/PCR
was performed on 1 g of total RNA from C3H10T1/2 control cells
or cells treated with BMP-2. The RT/PCR was performed with
primers specific for mouse aggrecan, mouse type II collagen and
mouse -actin. The RT/PCR reaction products were electro-
phoresed by non-denaturing TBE-agarose (2%) and the gel was
stained with ethidium bromide. The bands corresponding to aggre-
can (500 basepairs), type II collagen (IIA form, 489 basepairs, IIB
form, 285 basepairs) and -actin (502 basepairs) are indicated.SUBTRACTIVE HYBRIDIZATION SCREEN INDEPENDENTLY
IDENTIFIES GENES WHOSE EXPRESSION PATTERNS ARE BOTH
UP- AND DOWN-REGULATED BY BMP-2
To begin to probe more thoroughly the molecular mech-
anisms underlying BMP-2 mediated induction of chondro-
genesis, we performed a PCR-selected subtractivehybridization screen to identify genes whose expression is
either up- or down-regulated by BMP-2 in these micro-
mass cultures of C3H10T1/2 cells, during the period that
immediately precedes the overt expression of the chondro-
cyte phenotype. The rationale is that these genes could
play an important regulatory role in the initiation of the
differentiation process. The design for this screen is
26 M. W. Izzo et al.: Gene profiling during chondrogenesisFig. 2. Outline of the subtractive hybridization screen. Shown are the general steps used in the subtractive hybridization screen. The details
are outlined in the Material and methods and Results section. Only the screen for the BMP-2 inducible gene is shown. The screen for the
BMP-2-suppressible genes would be the opposite from that shown above, where the positions of the control RNA and BMP-2 stimulated
RNA would be reversed.schematized in Fig. 2. Total RNA was isolated from micro-
mass cultures of control and BMP-2 treated C3H10T1/2
cells at 24 h. The total RNA was used to make doublestranded cDNA, which was then digested with the restric-
tion endonuclease Rsa I to generate blunt ended cDNA
fragments.
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Summary of PCR-selected subtractive hybridization screen
Summary BMP up-regulated genes No. of
iterations
BMP-2 up-regulated screen Osteopontin 2
Total clones picked=107 -catenin 8
Total clones with insert=67 (62.6%) NIP3 4
Clones not sequenced=13 Ankhzn (ankyrin repeat/Zn-finger motif) 1
Total successful sequences=52/54 MRG-1 (MORF-related gene 1) 2
Novel sequences=24 (46.2%) Gremlin 4
mST1 (hsp70/hsp90 organizing protein) 3
m2 pyruvate kinase 3
U5 snRNP specific 200 kD protein (RNA helicase) 1
BMP-2 down-regulated screen BMP down-regulated genes
No. of
interations
Total clones picked=107 PARG-1 (PTPL1 associated Rho-GTPase) 2
Total clones with insert=89 (83.1%)
Clones not sequenced=18 SRPUL-like (Sushi-repeat up regulated in leukemiaa) 7
Total successful sequences=63/71 Cathepsin D 1
Novel sequences=47 (74.6%) KIAA0934 protein 3
Nuclear helicase BAT1 1
*Shown is a summary of the outcome of the subtractive hybridization screen. Listed on the left side are the total
number of white bacterial colonies picked, the number of plasmids containing detectable inserts (by restriction
enzyme digest of mini-prep plasmid DNA) and the total number of inserts sequenced. Also listed are the number
of novel genes and the number of known genes identified by BLAST searches of the sequence data. On the right
side the number of iterations indicates the number of times a particular insert appeared among the population of
recombinants.To identify genes whose expression is upregulated by
BMP-2, the cDNA from BMP-2 treated cells was divided
into two aliquots and each aliquot was ligated to a different
DNA linker at the 5′ end. The ends of these linkers do not
have a phosphate group and therefore only one linker
molecule will be ligated to each cDNA fragment. The cDNA
fragments with the ligated linkers were referred to as driver
samples no. 1 and no. 2, and were then hybridized separ-
ately with an excess of cDNA generated from the control
micromasses. In each hybridization there are five species
of molecules were generated: (1) unannealed driver cDNA,
(2) driver cDNA homodimers, (3) driver cDNA:control cDNA
heterodimers, (4) unannealed control cDNA and (5) control
cDNA homodimers. The resulting mixtures of driver
samples and control cDNA were combined and subjected
to a second round of hybridization without first denaturing
the samples. During this second hybridization the com-
plementary, unannealed driver cDNAs from both driver
samples annealed yielding double stranded cDNA frag-
ments that were unique to the BMP-2 treated micromasses.
These fragments will now have a different linker on either 5′
site. Next, using primers specific to each of the linkers,
rounds of PCR were performed to enrich for only those
molecules that were unique to the BMP-2 population.
To identify genes whose expression was down-regulated
by BMP-2 (i.e. the reverse screen) the above procedure
was repeated, with the exception that the untreated RNA
was used as the driver samples and the BMP-2 RNA was
used as the control. This screen should yield the PCR-
enriched fraction of cDNAs that were unique to the control
RNA.
Following the PCR reactions, the products were directly
cloned using TA-cloning method (see Materials and
methods) and the resultant clones were used to transform
bacteria, followed by blue/white selection to identify recom-
binants. The white colonies were grown, and the plasmids
were isolated, purified and restriction enzyme analysed to
determine the insert size. The inserts were sequencedand the information subjected to BLAST searches to
identify the genes. The outcome of this screening approach
is summarized in Table I.
For genes upregulated by BMP-2, 107 bacterial colonies
were analysed with 67 out of 107 plasmids (63%) contained
detectable inserts. Fifty-four inserts were sequenced, with
28 corresponding to known sequences, 24 were novel and
two inserts repeatedly failed to be sequenced. Table I lists
the identities of the known genes that showed up-regulation
by BMP-2 and the number of times they were isolated from
the screen.
Analysis of the genes that were down-regulated by
BMP-2 revealed a set that was distinct from the
up-regulated genes. As shown in Table I, 89 out of 107
plasmids (83%) had detectable inserts. Seventy-one
inserts were sequenced with 24 corresponding to known
sequences and 47 were found to be novel. Table I lists the
identities of the known genes that showed down-regulation
by BMP-2 and the number of times they were isolated from
the screen. Interestingly we did not find any redundancy in
the sequences identified as up-regulated genes with those
that were down-regulated, strongly suggesting that the
screen was successful in differentiating between the
enhanced and suppressed genes.
In order to verify and further characterize the expression
patterns of these genes the extent of differential expression
was analysed by slot blot hybridization. The plasmids
containing the cDNA inserts for the BMP-2 inducible genes
were individually spotted onto nitrocellulose. Two separate
nitrocellulose filters were generated; each containing an
identical array of the plasmids. Additionally, each filter
contained positive controls consisting of housekeeping
gene sequences [ actin, glyceraldehyde 3-phosphate
dehydrogenase (GAPDH), and cyclophilin] and a negative
control (the plasmid vector backbone). Next, equal
amounts of total cDNA prepared from the control cells and
from the BMP-2 treated cells were 32P-radiolabeled, and
hybridized separately with each filter array as described in
28 M. W. Izzo et al.: Gene profiling during chondrogenesisMaterials and methods. The amount of probe bound to
each plasmid on the filters was determined by densitometry
of the autoradiograph and is calculated as fold induction of
BMP-2 over control. The positive controls were used to
normalize for any differences in signal due to general
changes in gene expression. As shown in Fig. 3 (top), a
number of the sequences isolated from the screen for
BMP-2 induced genes displayed an increase in expression
of two-fold or more. The identities of these sequences, with
the accompanying level of induction by BMP-2, are shown
at the bottom of Fig. 3. The level of gene induction varied
between two-fold and 12-fold. Gremlin, pyruvate kinase
M2 and the novel gene 45U showed the highest levels
of induction by BMP-2 (10 and 12-fold, respectively).
These data therefore confirmed that this screening
approach effectively identified genes whose expression is
significantly elevated by BMP-2.
As a control in these experiments, we also assessed the
induction of the genes listed in Fig. 3, by BMP2 in mono-
layer culture. BMP2 does not induce chondrogenesis of
C3H10T1/2 cells in monolayer18,20. We find that the genes
listed in Fig. 3 were not induced by BMP2 in monolayer
culture (data not shown), indicating that the induction by
BMP2 is dependent on the micromass culture conditions
which lead to chondrogenesis.
The putative, BMP-2 down-regulated gene sequences
were analysed in a similar manner as that for the inducible
genes. As shown in Fig. 4 (top), a number of the sequences
displayed a decrease in expression of two-fold or greater.
The identifies of these genes, with the accompanying
level of suppression by BMP-2, are shown in the bottom of
Fig. 4. The level of gene suppression varies between
two-fold and seven fold. HSPC316 and the novel gene 26D
show the greatest level of suppression (six- and seven-fold,
respectively) by BMP-2. Again, these data confirmed the
utility of the approach in identifying genes whose expres-sion is significantly reduced by BMP-2. As a control in these
experiments, we also assessed the repression of the genes
listed in Fig. 4, by BMP2 in monolayer culture. We find that
the genes listed in Fig. 4 were not repressed by BMP2
in monolayer culture (data not shown), indicating that
their regulation of BMP2 is dependent on the micromass
conditions which lead to chondrogenesis.
Further confirmation of the up- and down-regulation of
the expression of these gene sequences by BMP-2 was
determined by RT/PCR using primers specific for select
members of these genes, namely gremlin, osteopontin,
-catenin, NIP3, BAT1 and SRPUL. Gremlin, osteopontin,
-catenin and NIP3 demonstrated an up-regulation in
mRNA levels in BMP-2 treated cultures, while BAT1 and
SRPUL demonstrated a down-regulation in mRNA levels in
response to BMP-2 (data not shown). Again, these data
confirmed the BMP-2 responsiveness of these genes.Table II
Summary of known/previously cloned genes isolated from subtractive screen
Accession no. Gene Description Function
BMP-2 up-regulated genes
NM 009818 -catenin Mus musculus catenin alpha 1 (Catna 1) Mediates cytoplasmic signaling by
N-cadherin
NM 009760 NIP3 Mus musculus BCL2/adenovirus E1B
19 kDa-interacting protein 1 (bnip3)
Pro-apoptotic mitochondrial protein
NM 011824 Gremlin Mus musculus Gremlin 1 (Gremlin 1-pending) BMP2 antagonist
U27830 mSTI1 Mus musculus mSTI1 Stress-inducible heat shock binding protein
S78177 Osteopontin Mus musculus Eta-1/Op (early T-lymphocyte
activator-1/osteopontin)
Non-collagenous bone matrix protein/cell
and matrix binding pro1
NM 011099 Pyruvate kinase m2 Mus musculus pyruvate kinase 3 (Pk3) Glycolytic enzyme
AC002477 PAC clone rp3-327a19 Homo sapiens PAC clone RP3-327A19 from
Xq25-q26, complete sequence
Unknown
AK001701 AK001701 Homo sapiens cDNA FLJ10839, clone
NT2RP4001276
Unknown
BMP-2 down-regulated genes
AF118128 BAT1 Mus musculus nuclear RNA helicase Bat1 (Bat1) Putative indispensable RNA helicase, exact
role unknown
AF060567 SRPUL Homo sapiens sushi-repeat protein upregulated
in leukemia (SRPUL)
Possible role in selectin-mediated adhesion
AK001449 BAA91699.1 Homo sapiens cDNA FLJ10587 fis, clone
NT2RP2004042
Unknown
AB023151 KIAA0934 Homo sapiens mRNA for KIAA0934 protein,
partial cds
Unknown
AF161434 HSPC316 Homo sapiens mRNA for HSPC316, partial cds Unknown
*Shown are the known or previously identified genes from Figs 3 and 4 that are up- and down-regulated by BMP-2 in micromass
cultures. The accession number, the name of the gene, a description of the gene along with its probable function are given.Discussion
In this study, we have utilized the BMP-2 induction of
chondrogenesis in micromass culture of C3H10T1/2 cells,
to isolate genes whose expression pattern is regulated by
BMP-2, as a first step in identifying the molecular players in
mediating chondrogenesis. The rationale for this approach
is that differentiation-enhancing proteins will need to be
up-regulated and differentiation-inhibitory proteins will need
to be suppressed in order for chondrogenesis to proceed
optimally. We therefore focused on cloning the genes that
are both up-regulated and down-regulated by BMP-2 dur-
ing this process. We used a differential screening method,
that of subtractive hybridization, to identify these regulated
genes. Using this approach we have successfully cloned
and identified a large number of genes that are regulated
by BMP-2 in this chondrogenic system.
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7U -catenin 416 378/378 (100%) NM
–
009818 3
81U NIP3 576 101/101 (100%) NM
–
009760 2
91U Gremlin 580 460/462 (99%) NM
–
011824 10
49U mSTI1 515 415/436 (95%) U27830 4
44U AK001701 462 376/412 (91%) AK001701 4
18U Osteopontin 712 349/356 (98%) S78177 3
95U PAC clone rp3-327a19 348 216/242 (89%) AC002477 4
47U Pyruvate kinase m2 1008 771/807 (95%) NM
–
011099 10
20U Novel* 986 na na 2
45U Novel* 619 na na 12
53U Novel* 727 na na 3
56U Novel* 281 na na 3
82U Novel* 310 na na 7
6U Novel* 534 na na 3
80U Novel* 392 na na 4
94U Novel* 280 na na 5
Fig. 3. Slot blot analysis of genes whose expression is up-regulated by BMP-2 in micromass culture. Plasmids containing the upregulated
genes indicated in the top half of the figure were spotted (0.8 g/spot) on to duplicate nitrocellulose filters. Each filter array was then probed
with 32P-radiolabeled cDNA (1×106 CPM/ml) derived from either control micromass cultures (not BMP-2 treated) or from micromass cultures
treated with BMP-2 (75 ng/ml) for 48 h. As controls, -actin, glyceraldehyde phosphate dehydrogenase (GAPDH), cyclophilin, and the
plasmid vector only were spotted onto the filters. The filters were hybridized with the probes and then washed under high stringency
conditions. The blots were exposed to X-ray film and the films scanned using Kodak 2D software with a Kodak Image Station 440. Top. The
relative levels of induction are shown corrected for any differences in the levels of expression of -actin, GAPDH and cyclophilin. Those
genes that did not give at least a two-fold induction were not included in the graphs. Bottom. Detailed information on each of gene, including
fold induction by BMP-2, accession number, insert size and extent of alignment with published sequences from the BLAST database.When the up-regulated genes are examined it is
apparent that some of the members of this group fall into
a category of genes expected to be induced by BMP-2
(Table II). These genes include -catenin, osteopontin and
pyruvate kinase. -catenin is known to couple N-cadherin
cell–cell signaling to the cytoskeleton. Given that
N-cadherin expression is needed for induction ofchondrogenesis in vivo and in vitro20,35,36, it is interesting
that one component of the pathway is up-regulated during
this process. This may imply that -catenin contributes
positively to the N-cadherin mediated cell-signaling and
cell–cell interaction needed for optimal chondrogenesis.
Additionally, it has been shown in recent studies that
-catenin can antagonize -catenin signaling.37–39 Ectopic
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31D BAT1 335 326/327 (99%) AF118128 3
53D BAA91699.1 395 308/340 (90%) AK001499 2
74D KIAA0934 810 514/587 (87%) AB023151 3
24D HSPC316 387 325/364 (89%) AF161434 6
79D SRPUL 579 250/286 (87%) AF060567 4
4D Novel* 410 na na 5
14D Novel* 637 na na 4
26D Novel* 219 na na 7
82D Novel* 598 na na 4
3D Novel* 533 na na 3
87D Novel* 220 na na 4
89D Novel* 328 na na 2
*Note that all of the novel sequences are different from each other.
Fig. 4. Slot blot analysis of genes whose expression is down regulated by BMP-2 in micromass culture. Plasmids containing the
down-regulated genes indicated in the bottom half of the figure were spotted (10 g/spot) onto duplicate nitrocellulose filters. Each filter array
was then probed with 32P-radiolabeled cDNA (1×106 CPM/ml) derived from either control micromass cultures (not BMP-2 treated) or from
micromass cultures treated with BMP-2 (75 ng/ml) for 48 h. As controls, -actin, glyceraldehyde phosphate dehydrogenase (GAPDH),
cyclophilin, and the plasmid vector only were spotted on to the filters. The filters were hybridized with the probes and then washed under high
stringency conditions. The blots were exposed to X-ray film and the films scanned using Kodak 2D software with a Kodak Image Station 440.
Top. The relative levels of induction are shown, corrected for any differences in the levels of expression of -actin, GADPH and cyclophilin.
Those genes that did not give at least a two-fold suppression were not included in the graph. Bottom. Detailed information on each of gene,
including fold suppression by BMP-2, accession number, insert size and extent of alignment with published sequences from the BLAST
database.expression of -catenin has been shown to inhibit
-catenin-TCF/LEF signaling, and -catenin disrupts the
interaction of the -catenin-TCF/LEF complex and DNA
in vitro38. This potential regulatory role could be important
in the modulation of antichondrogenic signaling through the
Wnt pathway.
Osteopontin, a sulfated phosphoprotein, is present in the
extracellular matrix of a variety of tissues, particularly bone
and cartilage. Osteopontin has been demonstrated to be
expressed in hypertrophic chondrocytes and osteo-blasts40,41. The up-regulation of osteopontin seems to be
consistent with the finding that the cells in this culture
system are undergoing chondrogenesis.
The other known genes may also play interesting roles in
BMP-2 induced chondrogenesis. For example, gremlin is
a BMP-2 antagonist42. Its probable role may be one of
homeostasis, i.e., to limit or reduce the extent of BMP-2
induced signaling, and thereby control the extent of
chondrogenesis that ultimately takes place. Of additional
relevance is the finding that gremlin may also play a role in
Osteoarthritis and Cartilage Vol. 10, No. 1 31the modulation of tissue regression and cell death in the
interdigital space of the developing chick limb bud which is
BMP-2/4 dependent43,44.
BNIP3 is a pro-apoptotic protein that heterodimerizes
with Bcl-2 and Bcl-XL45. Induction of BNIP3 may be
required to control cell number during chondrogenesis.
That BNIP3 is induced in this C3H10T1/2 system is con-
sistent with our observation that hypertrophy may occur in
late stages of the chondrifying micromass cultures (Pucci
et al., unpublished observations). Thus an up-regulation of
a pro-apoptotic protein may presage the onset of apoptosis
that would occur during chondrocyte maturation.
mSTI1 is a stress inducible, heat shock protein that is the
murine ortholog of yeast STI1. This gene is alternatively
known as hsp70/hsp90 organizing protein (HOP), p60, and
isoelectric focusing sample spot 3521 (IEF SSP 3521)46,47.
mSTI1 is an indispensable component of a dynamic com-
plex chaperoning machine that is involved with the func-
tional maturation of a number of protein substrates48–51.
This multimolecule complex helps to fold proteins such
as the glucocorticoid receptor52,53. There are multiple
members of this heterocomplex, including hsp70, hsp40,
and the hsp70-interacting protein (Hip). The complex has
additional transient members which include hsc70 and
hsp90, whose binding to the heterocomplex is mediated by
mSTI1. the co-chaperones of mSTI1, hsp70, hsc70, and
hsp90 are expressed to varying degrees during endo-
chondral bone formation in the mouse embryo54. Con-
sidering the vast array of extracellular matrix proteins that
chondrocytes produce, it is reasonable to assume that
mSTI1 may play a role in the maturation and folding of
these proteins.
Pyruvate kinase M2 (PKM2) is an enzyme that is
involved in the anaerobic metabolism of glucose, and is
seen here to be up-regulated in C3H10T1/2 cells treated
with BMP-2, as well as in articular cartilage. This effect is
consistent with the increased rate of glycolysis character-
istic of the relatively avascular cartilaginous tissues41,55.
Recent studies have also demonstrated that the activity of
PKM2 and other glycolytic enzymes in several cell types
dramatically increase with treatment with TGF-1, TGF-3
and other soluble growth factors56–58. BMP-2, a member of
the TGF- superfamily, might thus also have a regulatory
effect on PKM2.
Examination of the BMP-2 down-regulated genes did not
reveal obvious candidate genes that may be involved in the
suppression of chondrogenesis (Table II). These BMP-2
down-regulated genes include the putative RNA helicase
BAT1 and a sushi-repeat prtoein, SRPUL. BAT1 has been
described as a DEAD-box containing protein that may also
be a RNA helicase59,60. DEAD-box protein family members
are involved in a wide array of activities in the cell, including
pre-mRNA splicing, ribosome biogenesis, nucleo-
cytoplasmic transport, translation, RNA decay, and organel-
lar gene expression61. At this time it is not known how
suppression of RNA-helicase activity in BAT1 may con-
tribute to chondrogenesis. SRPUL, on the other hand, was
first described as a downstream target of the oncogene
E2A-HLF and as having a potential role in selectin-
mediated adhesion62. As with BAT1, it is not obvious how
suppression of SRPUL contributes to chondrogenesis.
It is interesting to note the large number of unknown
genes identified in this screen. Over half of the genes were
not present in the databases. Five sequences that were
found to be either up-regulated (PAC clone rp3-327A19
and FLJ10839) or down-regulated (FLJ10587, KIAA0934
and HSPC316) by BMP-2 have been identified by genome/cDNA sequencing, but as yet have no known function.
Isolation of the corresponding full-length cDNAs and infor-
mation on the sequence of the open reading frames will
enable us to deduce possible protein functions by the
comparison of any structural motifs with those of other
proteins in the databases.
Finally, it is noteworthy that the two groups of genes
(i.e. up and down regulated ones) do not show any redun-
dancy in terms of sequence identity, indicating that the
PCR-selected subtractive hybridization approach was suc-
cessful in identifying unique categories of genes. Our
challenge is to determine the functional roles of these gene
products in the mesenchymal chondrogenesis process and
in the onset of osteoarthritis.Acknowledgments
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